Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo
Clinical trial NCT04530344 · COMPLETED
Trial details
- NCT number
- NCT04530344
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-24
- Primary completion
- 2022-11-14
- Enrollment
- 458
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.